Sun Pharmaceutical Industries Ltd. announced that one of its wholly owned subsidiaries has launched the generic versions of Glumetza (metformin hydrochloride) extended release tablets, 500 mg...
The recently announced acquisition of Apotex International’s commercial operations in five European countries by Aurobindo Pharma Limited, once completed, will narrow the gap between the company’s...
Corner Store Technologies, a Jaipur based subscription pharmacy that operates under the brand LifCare, has raised USD 11 million Series B from SAIF Partners, Nexus Ventures,...
Boston Scientific Corporation has been notified of an unsolicited mini-tender offer by TRC Capital Corporation (TRC) to purchase up to three million shares of Boston Scientific’s...
Thermo Fisher Scientific Inc., the world leader in serving science, today reported its financial results for the second quarter ended June 30, 2018. Second quarter 2018 highlights...
The Board of Directors of BD (Becton, Dickinson and Company) has declared a quarterly dividend of USD 0.75 per common share, payable on September 28, 2018 to holders of record...
Sysmex America and Advanced Instruments announced a partnership today that will broaden the Sysmex portfolio with Advanced Instruments’ automated GloCyte cell counter system. The technology provides...
Pfizer announced it will increase its commitment to US manufacturing with a USD 465 million investment to build one of the most technically advanced sterile injectable pharmaceutical...
3M reported second-quarter 2018 results. “3M had a strong quarter, including organic growth of 6 percent that was broad-based across all business groups and geographic areas,”...
Bristol-Myers Squibb Company and Tsinghua University, have entered into a collaboration to discover therapeutic agents against novel targets for autoimmune diseases and cancers. The collaboration brings...
Waters Corporation announced second quarter 2018 sales of USD 596 million, a 7 percent increase as reported, versus sales of USD 558 million for the second...
GlaxoSmithKline plc and Adaptimmune Therapeutics plc, a leader in T-cell therapy to treat cancer, today announced the transition of the development program for GSK3377794 (GSK ‘794),...
The global skin rejuvenation devices market was valued at USD 1478 million in 2017, and is projected to exhibit a CAGR of 9.3 percent from 2018...
The global market for inhalation and nasal spray generic drugs is highly fragmented in nature with a high level of competition among the key players. The...
Global drug abuse treatment market was valued at USD 13.4 billion in 2017, and is projected to exhibit a CAGR of 7.8 percent from 2018 –...
Copyright © 2024 Medical Buyer